Quest Diagnostics (DGX) Receivables - Other (2009 - 2021)

Quest Diagnostics has reported Receivables - Other for 9 years, with the latest figure at $5.0 million in Q1 2021.

• Quarterly Receivables - Other changed 0.0% year-over-year to $5.0 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $5.0 million (changed 0.0% YoY) and the FY2020 annual result came in at $3.0 million, down 25.0% from the prior year.
• Receivables - Other improved to $5.0 million in Q1 2021 per DGX's latest filing, from $3.0 million in the prior quarter.
• Over five years, Receivables - Other peaked at $13.0 million in Q2 2017 and troughed at $3.0 million in Q4 2017.
• A 5-year average of $4.9 million and a median of $4.0 million in 2018 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2017 and 2018: Receivables - Other surged 83.33% in 2017, then sank 76.92% in 2018.
• Over 5 years, Receivables - Other stood at $3.0 million in 2017, then changed by 0.0% to $3.0 million in 2018, then jumped by 33.33% to $4.0 million in 2019, then retreated by 25.0% to $3.0 million in 2020, then soared by 66.67% to $5.0 million in 2021.
• According to Business Quant data, Receivables - Other over the past three periods registered $5.0 million, $3.0 million, and $4.0 million for Q1 2021, Q4 2020, and Q3 2020 respectively.